Logo image of OM

OUTSET MEDICAL INC (OM) Stock Fundamental Analysis

NASDAQ:OM - Nasdaq - US6901451079 - Common Stock - Currency: USD

0.8754  -0.08 (-8.81%)

After market: 0.86 -0.02 (-1.76%)

Fundamental Rating

2

OM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. While OM seems to be doing ok healthwise, there are quite some concerns on its profitability. OM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year OM has reported negative net income.
OM had a negative operating cash flow in the past year.
OM had negative earnings in each of the past 5 years.
OM had a negative operating cash flow in each of the past 5 years.
OM Yearly Net Income VS EBIT VS OCF VS FCFOM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -50M -100M -150M

1.2 Ratios

OM has a worse Return On Assets (-48.12%) than 66.49% of its industry peers.
With a Return On Equity value of -294.71%, OM is not doing good in the industry: 82.98% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -48.12%
ROE -294.71%
ROIC N/A
ROA(3y)-41.42%
ROA(5y)-48.12%
ROE(3y)-80.71%
ROE(5y)-99.1%
ROIC(3y)N/A
ROIC(5y)N/A
OM Yearly ROA, ROE, ROICOM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -50 -100 -150 -200

1.3 Margins

Looking at the Gross Margin, with a value of 30.97%, OM is doing worse than 75.00% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for OM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OM Yearly Profit, Operating, Gross MarginsOM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K

More info and screens

4

2. Health

2.1 Basic Checks

OM does not have a ROIC to compare to the WACC, probably because it is not profitable.
OM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OM Yearly Shares OutstandingOM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
OM Yearly Total Debt VS Total AssetsOM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

OM has an Altman-Z score of -5.07. This is a bad value and indicates that OM is not financially healthy and even has some risk of bankruptcy.
OM has a Altman-Z score of -5.07. This is in the lower half of the industry: OM underperforms 70.21% of its industry peers.
A Debt/Equity ratio of 4.12 is on the high side and indicates that OM has dependencies on debt financing.
OM has a Debt to Equity ratio of 4.12. This is amonst the worse of the industry: OM underperforms 88.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.12
Debt/FCF N/A
Altman-Z -5.07
ROIC/WACCN/A
WACC7.49%
OM Yearly LT Debt VS Equity VS FCFOM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 6.49 indicates that OM has no problem at all paying its short term obligations.
The Current ratio of OM (6.49) is better than 86.17% of its industry peers.
OM has a Quick Ratio of 5.04. This indicates that OM is financially healthy and has no problem in meeting its short term obligations.
OM has a Quick ratio of 5.04. This is amongst the best in the industry. OM outperforms 82.45% of its industry peers.
Industry RankSector Rank
Current Ratio 6.49
Quick Ratio 5.04
OM Yearly Current Assets VS Current LiabilitesOM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.94% over the past year.
EPS 1Y (TTM)41.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.4%

3.2 Future

The Earnings Per Share is expected to grow by 14.74% on average over the next years. This is quite good.
The Revenue is expected to grow by 13.37% on average over the next years. This is quite good.
EPS Next Y50.5%
EPS Next 2Y28.27%
EPS Next 3Y12.83%
EPS Next 5Y14.74%
Revenue Next Year7.67%
Revenue Next 2Y7.06%
Revenue Next 3Y11.89%
Revenue Next 5Y13.37%

3.3 Evolution

OM Yearly Revenue VS EstimatesOM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
OM Yearly EPS VS EstimatesOM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2 -3 -4 -5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OM Price Earnings VS Forward Price EarningsOM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OM Per share dataOM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as OM's earnings are expected to grow with 12.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.27%
EPS Next 3Y12.83%

More info and screens

0

5. Dividend

5.1 Amount

OM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OUTSET MEDICAL INC

NASDAQ:OM (2/21/2025, 8:00:01 PM)

After market: 0.86 -0.02 (-1.76%)

0.8754

-0.08 (-8.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners96.45%
Inst Owner Change-21.34%
Ins Owners1.91%
Ins Owner Change-5.78%
Market Cap47.01M
Analysts83.08
Price Target3.83 (337.51%)
Short Float %17.32%
Short Ratio8.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.59%
Min EPS beat(2)-1.03%
Max EPS beat(2)10.2%
EPS beat(4)2
Avg EPS beat(4)3.79%
Min EPS beat(4)-1.03%
Max EPS beat(4)10.2%
EPS beat(8)3
Avg EPS beat(8)-2.21%
EPS beat(12)3
Avg EPS beat(12)-5.23%
EPS beat(16)6
Avg EPS beat(16)-2.15%
Revenue beat(2)1
Avg Revenue beat(2)-5.65%
Min Revenue beat(2)-14.74%
Max Revenue beat(2)3.44%
Revenue beat(4)1
Avg Revenue beat(4)-5.94%
Min Revenue beat(4)-14.74%
Max Revenue beat(4)3.44%
Revenue beat(8)4
Avg Revenue beat(8)-2.92%
Revenue beat(12)6
Avg Revenue beat(12)-2.17%
Revenue beat(16)10
Avg Revenue beat(16)0.27%
PT rev (1m)-6.25%
PT rev (3m)19.05%
EPS NQ rev (1m)-2.27%
EPS NQ rev (3m)-4.87%
EPS NY rev (1m)-0.41%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)2.01%
Revenue NQ rev (3m)2.15%
Revenue NY rev (1m)0.39%
Revenue NY rev (3m)0.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.41
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)-1.8
EYN/A
EPS(NY)-0.89
Fwd EYN/A
FCF(TTM)-2.35
FCFYN/A
OCF(TTM)-2.31
OCFYN/A
SpS2.14
BVpS0.89
TBVpS0.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -48.12%
ROE -294.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.97%
FCFM N/A
ROA(3y)-41.42%
ROA(5y)-48.12%
ROE(3y)-80.71%
ROE(5y)-99.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 4.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.25%
Cap/Sales 1.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.49
Quick Ratio 5.04
Altman-Z -5.07
F-Score4
WACC7.49%
ROIC/WACCN/A
Cap/Depr(3y)93.53%
Cap/Depr(5y)158.24%
Cap/Sales(3y)4.3%
Cap/Sales(5y)10.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.29%
EPS Next Y50.5%
EPS Next 2Y28.27%
EPS Next 3Y12.83%
EPS Next 5Y14.74%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.4%
Revenue Next Year7.67%
Revenue Next 2Y7.06%
Revenue Next 3Y11.89%
Revenue Next 5Y13.37%
EBIT growth 1Y25.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.37%
EBIT Next 3Y19.1%
EBIT Next 5Y14.15%
FCF growth 1Y16.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.64%
OCF growth 3YN/A
OCF growth 5YN/A